Growth hormone releasing peptides
Your pituitary gland releases growth hormone in pulses, mostly at night, and that output declines with age. Growth hormone releasing peptides — sermorelin, ipamorelin, CJC-1295, tesamorelin — are studied for nudging the body's own pulses rather than replacing the hormone outright.
The articles below cover how each one works, how they differ from one another and from HGH itself, and what the research does and doesn't show. All of them are prescription-only through Promise: a licensed provider reviews every request.
69 articles on this topic
-
Sermorelin Injections: Sites and Expectations
Sermorelin is injected into the fatty layer beneath the skin, commonly around bedtime. The dose, schedule, site plan, and storage instructions come from the prescriber and dispensing pharmacy—not a universal online protocol.
-
How Long Do Peptides Take to Work?
Peptide timelines range from hours on a lab test to months on a scale. The useful answer depends on the molecule, the outcome being measured and the quality of the evidence behind it.
-
Peptides With Semaglutide: What the Evidence Says
Evidence gaps depend on the specific peptide combined with semaglutide; [cagrilintide–semaglutide has randomized phase 3 trial data](https://pubmed.ncbi.nlm.nih.gov/40544433/), while the combinations discussed here do not. A provider has to judge each compound on its own evidence, risks, and purpose.
-
What Are Peptides? A Plain-English Guide
Peptides are short chains of amino acids that the body uses as signals. The same broad family includes natural hormones, established medicines and experimental compounds, so the name alone says little about evidence or safety.
-
Peptides vs Steroids: What Makes Them Different?
Peptides and anabolic steroids are different molecules with different targets, evidence, risks, and legal status. A peptide is not simply a steroid under a newer name.
-
Tesamorelin for Belly Fat: What the Studies Show
Tesamorelin has reduced visceral abdominal fat in randomized trials, most convincingly in adults with HIV-associated lipodystrophy. That evidence does not make it a general weight-loss drug or a reliable way to shrink the fat just under the skin.
-
Tesamorelin vs Ipamorelin: What Sets Them Apart
Both peptides signal the pituitary to release growth hormone, but they use different receptors and carry very different levels of human evidence. Tesamorelin has phase 3 trial data; ipamorelin does not.
-
Peptides for Muscle Growth: Evidence and Limits
Prescription GH-axis peptides can change hormone levels and, in selected patients, body composition. Human evidence does not show that they produce hypertrophy or greater strength in healthy trained adults.
-
Sermorelin for Women: Evidence and Menopause
Sermorelin can raise growth-hormone output in women when the pituitary responds, but female-specific trials are small and mostly use related GHRH compounds. It is not menopause hormone therapy, and the evidence does not show reliable gains in sleep, libido or lean mass for women.
-
How to Store Peptides: Fridge, Freezer, and Travel
Reconstituted peptide vials are commonly refrigerated at 2–8 °C, but the pharmacy label and beyond-use date always control. Lyophilized powders and commercial pens may have different limits.
-
Best HGH Peptides: A Best-Fit Comparison
The best HGH peptides are not a strongest-to-weakest ranking. The useful comparison is which receptor they use, how long they act, and whether the evidence matches the reason a clinician is considering them.
-
Tesamorelin Side Effects: Rates, Risks, Monitoring
The most common tesamorelin side effects are injection-site reactions and joint pain; glucose, IGF-1 and cancer history are the monitoring issues that can change the plan.
-
CJC-1295 No DAC: What the Label Actually Means
CJC-1295 no DAC is label shorthand for modified GRF 1-29, a short-acting GHRH analog without the albumin-binding feature that makes the DAC form last for days.
-
Ipamorelin Side Effects: What Human Data Shows
Human safety data for ipamorelin are unusually thin. Short-term reports exist, but no published trial tells us how common side effects are with months or years of compounded use.
-
Sermorelin vs Ipamorelin: Two Different Receptors
Sermorelin copies the hypothalamus and clears in about four minutes. Ipamorelin copies ghrelin and lasts roughly two hours. The receptor each one binds explains almost everything else about them.
-
Tesamorelin Ipamorelin: Two Receptors, One Vial
Two peptides, two pituitary receptors, one vial. Each half has a research record of its own; the combination has never been tested as a combination.
-
Does Sermorelin Work? What Human Studies Show
Small human studies show that sermorelin can increase growth hormone output, but IGF-1 and body-composition results are inconsistent. Whether it is working should be judged with labs and a prescriber, not a feeling or a promised calendar.
-
Tesamorelin vs Sermorelin: What Actually Differs
Both are growth-hormone-releasing hormone analogues and they are not interchangeable: one is a 44-amino-acid molecule with a current US approval, the other a 29-amino-acid fragment whose branded product left the market in 2008.
-
Sermorelin vs CJC-1295: What Actually Differs
Both signal the pituitary through the GHRH pathway. The practical difference is duration: sermorelin is brief, while DAC-bearing CJC-1295 was engineered to remain active far longer.
-
Tesamorelin Dosage: How Prescribers Set It
Tesamorelin is dosed daily in the trials and current brand label, but the milligram amount depends on the formulation. IGF-1, glucose, indication and tolerability matter more than a copied schedule.
Page 3 of 4 · 69 articles